$12.00 (-2.20%)

Volume: 237.563k

Closed: Jan 27, 2023

Hollow Logo Score: 2.707
Cara Therapeutics Stock
$12.00 (-2.20%)

Volume: 237.563k

Closed: Jan 27, 2023

Score Hollow Logo 2.707
NASDAQ:CARA

Cara Therapeutics Stock Statistics

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Dates Signal Change
2023-01-19 - 2023-01-27 BUY 4.90
2023-01-18 - 2023-01-19 SELL 4.76
2023-01-17 - 2023-01-18 HOLD 1.87
2023-01-12 - 2023-01-17 SELL 1.71
2023-01-10 - 2023-01-12 HOLD 3.84

Stock Score Effectiveness

Bollinger Stock Signal Effectiveness

Macd Signal Effectiveness

Mv7 Signal Effectiveness

Score signal

Bollinger Signal Statistics

MV signal statistics

MACD Signal Statistics

Hot Stocks To Watch:

About Cara Therapeutics

Cara Therapeutics Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of mod... CARA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT